TY - CHAP
T1 - Future of escherichia coli research in Latin America
AU - Gomes, Tânia A.T.
AU - Ibarra, Cristina
AU - Navarro-Garcia, Fernando
AU - Palermo, Marina
AU - Prado, Valeria
AU - Rivas, Marta
AU - Torres, Alfredo G.
PY - 2010
Y1 - 2010
N2 - In the 21st century, diarrhea is still a leading cause of illness and death especially in children in Latin American countries. ETEC, EHEC, EPEC, and EAEC remain as the major categories of pathogenic E. coli associated with diarrheal disease; however, it is evident that a shift in the serotypes responsible for human disease is occurring in this region. Recent reports implicated atypical EPEC as an important emerging category of E. coli and the association of EHEC O157:H7 as a cause of hemolytic uremic syndrome in Latin America is becoming evident. Significant improvements are required in the area of early diagnosis to increase the likelihood of an effective treatment. In this region, very few studies have addressed the emergence of antimicrobial resistance and high asymptomatic carriage rates for diarrheagenic E. coli (DEC), as well as non-human reservoirs and vehicles of transmission, are largely unknown. It is evident that broadening the epidemiological surveys to include emerging and re-emerging categories of DECs while increasing the capabilities of detection and novel treatment is a priority for the future of the E. coli research in Latin America.
AB - In the 21st century, diarrhea is still a leading cause of illness and death especially in children in Latin American countries. ETEC, EHEC, EPEC, and EAEC remain as the major categories of pathogenic E. coli associated with diarrheal disease; however, it is evident that a shift in the serotypes responsible for human disease is occurring in this region. Recent reports implicated atypical EPEC as an important emerging category of E. coli and the association of EHEC O157:H7 as a cause of hemolytic uremic syndrome in Latin America is becoming evident. Significant improvements are required in the area of early diagnosis to increase the likelihood of an effective treatment. In this region, very few studies have addressed the emergence of antimicrobial resistance and high asymptomatic carriage rates for diarrheagenic E. coli (DEC), as well as non-human reservoirs and vehicles of transmission, are largely unknown. It is evident that broadening the epidemiological surveys to include emerging and re-emerging categories of DECs while increasing the capabilities of detection and novel treatment is a priority for the future of the E. coli research in Latin America.
UR - http://www.scopus.com/inward/record.url?scp=84884733641&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884733641&partnerID=8YFLogxK
U2 - 10.2174/978160805192211001010256
DO - 10.2174/978160805192211001010256
M3 - Chapter
AN - SCOPUS:84884733641
SN - 9781608055715
SP - 256
EP - 261
BT - Pathogenic Escherichia coli in Latin America
PB - Bentham Science Publishers Ltd.
ER -